Role of nitric oxide in the haemodynamic effects of growth hormone.
Böger
R H
RH
Institute of Clinical Pharmacology, Hannover Medical School, Germany.
D001161:Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D019382:Human Growth Hormone / Q000172:deficiency / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism / Q000494:pharmacology; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology; D009569:Nitric Oxide / Q000378:metabolism* / Q000627:therapeutic use
D019382:Human Growth Hormone; D009569:Nitric Oxide; D007334:Insulin-Like Growth Factor I